Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03348280 · ClinicalTrials.gov registry record

Vitamin D and Immune Mechanisms of Hypertension in Type 2 Diabetics

A clinical trial of Hypertension and Diabetes Mellitus, Type 2, sponsored by Washington University School of Medicine.

Active
Registry status
40
Enrollment target
2
Study locations

NCT03348280 is a study of Hypertension and Diabetes Mellitus, Type 2 that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 40 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03348280, a study of Hypertension and Diabetes Mellitus, Type 2, is active but no longer recruiting, sponsored by Washington University School of Medicine.

ACTIVE NOT RECRUITING
Registry status
40 participants
Enrollment target
2
Study locations

Study Summary

This trial will evaluate whether a particular type of circulating white blood cell, monocytes, from type 2 diabetics with high blood pressure and vitamin D deficiency vs. sufficiency will induce hormones that increase blood pressure.

Interventions

  • DIAGNOSTIC_TEST Blood draw

Study Locations (2)

Missouri

  • Barnes-Jewish & Washington University Diabetes Center - St Louis
  • Washington University - St Louis

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-09-01
Est. Completion 2026-12-31

What the Registry Record Tells You About NCT03348280

The ClinicalTrials.gov registry entry for NCT03348280 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.

NCT03348280 reports 2 study locations spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03348280 about?

NCT03348280 is a clinical study titled "Vitamin D and Immune Mechanisms of Hypertension in Type 2 Diabetics". This trial will evaluate whether a particular type of circulating white blood cell, monocytes, from type 2 diabetics with high blood pressure and vitamin D deficiency vs. sufficiency will induce hormones that increase blood pressure.

What is the current status of trial NCT03348280?

This trial is currently active not recruiting. The enrollment target is 40 participants. The study started on 2017-09-01. Estimated completion is 2026-12-31.

What conditions does trial NCT03348280 study?

This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus, Type 2, Vitamin D Deficiency.

What interventions are being tested in trial NCT03348280?

The interventions under investigation include: Blood draw (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03348280?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03348280 being conducted?

This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.